首页> 美国卫生研究院文献>Journal of Cellular and Molecular Medicine >Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer
【2h】

Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer

机译:导入慢病毒基因转移后表达hTERT的人源间充质干细胞的单细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human mesenchymal stem cells (hMSCs) can be readily isolated from bone marrow and differentiate into multiple tissues, making them a promising target for future cell and gene therapy applications. The low frequency of hMSCs in bone marrow necessitates their isolation and expansion in vitro prior to clinical use, but due to senescence-associated growth arrest during culture, limited cell numbers can be generated. The lifespan of hMSCs has been extended by ectopic expression of human telomerase reverse transcriptase (hTERT) using retroviral vectors. Since malignant transformation was observed in hMSCs and retroviral vectors cause insertional mutagenesis, we ectopically expressed hTERT using lentiviral gene transfer. Single-cell-derived hMSC clones expressing hTERT did not show malignant transformation in vitro and in vivo after extended culture periods. There were no changes observed in the expression of tumour suppressor genes and karyotype. Cultured hMSCs lack telomerase activity, but it was significantly increased by ectopic expression of hTERT. HTERT expression prevented hMSC senescence and the cells showed significantly higher and unlimited proliferation capacity. Even after an extended culture period, hMSCs expressing hTERT preserved their stem cells character as shown by osteogenic, adipogenic and chon-drogenic differentiation. In summary, extending the lifespan of human mesenchymal stem cells by ectopic expression of hTERT using lentiviral gene transfer may be an attractive and safe way to generate appropriate cell numbers for cell and gene therapy applications.
机译:人间充质干细胞(hMSCs)可以很容易地从骨髓中分离出来并分化为多种组织,这使其成为未来细胞和基因治疗应用的有希望的靶标。骨髓中hMSC的频率低,需要在临床使用之前在体外进行分离和扩增,但是由于培养过程中与衰老相关的生长停滞,只能产生有限的细胞数。通过使用逆转录病毒载体异位表达人类端粒酶逆转录酶(hTERT),可以延长hMSC的寿命。由于在hMSC中观察到恶性转化,逆转录病毒载体引起插入诱变,因此我们使用慢病毒基因转移来异位表达hTERT。延长培养时间后,表达hTERT的单细胞来源hMSC克隆在体外和体内均未显示出恶性转化。没有观察到肿瘤抑制基因的表达和核型的变化。培养的hMSC缺乏端粒酶活性,但是通过异位表达hTERT显着增加了端粒酶活性。 HTERT表达阻止了hMSC的衰老,并且细胞显示出更高的无限增殖能力。即使经过延长的培养期,表达hTERT的hMSC仍保留了其干细胞的特性,如成骨,成脂和软骨成因分化所示。总之,使用慢病毒基因转移通过hTERT的异位表达来延长人间充质干细胞的寿命,可能是一种吸引人且安全的方法,可以为细胞和基因治疗应用生成合适的细胞数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号